Targeting STAT3 anti-apoptosis pathways with organic and hybrid organic–inorganic inhibitors-Reference-Cited by-同舟云学术

Targeting STAT3 anti-apoptosis pathways with organic and hybrid organic–inorganic inhibitors

Published:2020 Issue:17 Volume:18 Page:3288-3296
ISSN:1477-0520
Container-title:Organic & Biomolecular Chemistry
language:en
Short-container-title:Org. Biomol. Chem.

Author:

Minus Matthew B.¹²³⁴⁵,Wang Haopei⁴⁵⁶³,Munoz Jaime O.⁷⁸⁶³,Stevens Alexandra M.⁷⁸⁶³,Mangubat-Medina Alicia E.⁴⁵⁶³,Krueger Michael J.⁷⁸⁶³,Liu Wei⁷⁸⁶³,Kasembeli Moses M.⁹¹⁰¹¹⁶³,Cooper Julian C.⁴⁵⁶³,Kolosov Mikhail I.¹²⁷⁶³,Tweardy David J.⁹¹⁰¹¹⁶³,Redell Michele S.⁷⁸⁶³,Ball Zachary T.⁴⁵⁶³^ORCID

Affiliation:

1. Prairieview A&M University

2. Prairie View

3. USA

4. Department of Chemistry

5. Rice University

6. Houston

7. Baylor College of Medicine

8. Texas Children's Cancer Center

9. Department of Infectious Diseases

10. Infection Control and Employee Health

11. The University of Texas MD Anderson Cancer Center

12. Department of Medicine

Abstract

Recurrence and drug resistance are major challenges in the treatment of acute myeloid leukemia (AML) that spur efforts to identify new clinical targets and active agents.

Funder

National Cancer Institute

Welch Foundation

Division of Chemistry

Gillson Longenbaugh Foundation

Simmons Family Foundation

Publisher

Royal Society of Chemistry (RSC)

Subject

Organic Chemistry,Physical and Theoretical Chemistry,Biochemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2020/OB/C9OB02682G